908 Devices is revolutionizing chemical analysis with our simple handheld devices for forensics and field detection.

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices. 03.04.25. 908 Devices to Participate in Upcoming Investor Conferences. 03.03.25. 908 Devices to Report Fourth …

Explore career opportunities at 908 Devices! Join our passionate team working on cutting-edge technologies in mass spec and field detection.

On which stock exchange are 908 Devices’ shares traded, what is the ticker symbol and when did it go public? Our common stock is traded on the Nasdaq Global Market under the symbol …

Mar 4, 2025 · 908 Devices cements its unique position as a market-leading provider of analytical tools for tackling critical public health and safety crises through the divestiture of its …

Mar 3, 2025 · 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and full …

Mar 4, 2025 · WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)-- Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, …

Mar 4, 2025 · Products acquired from 908 Devices include MAVERICK and MAVEN for real-time monitoring and control of critical bioprocess parameters; REBEL, an at-line cell culture media …

The MX908’s capabilities are particularly beneficial for detecting synthetic drugs like nitazenes, offering coverage for 13 different nitazene analogs, both in its device and off-device libraries, …

Sep 6, 2024 · Traditional Liquid Chromatography-Mass Spectrometry (LC-MS) has long been a cornerstone in this domain, renowned for its robustness and precision. However, as the …